Drew M. Pardoll | John-William Sidhom, M.D.,Ph.D.

Latest

Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade
Deep learning reveals predictive sequence concepts within immune repertoires to immunotherapy
Deep learning reveals predictive sequence concepts within immune repertoires to immunotherapy
Anti-PD-1 elicits regression of undifferentiated pleomorphic sarcomas with UV-mutation signatures
DeepTCR
DeepTCR is a deep learning framework for revealing sequence concepts within T-cell repertoires
ExCYT
Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in Melanoma
Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non–Small Cell Lung Cancer
High-Dimensional Cytometry (ExCYT) and Mass Spectrometry of myeloid infiltrate in clinically localized clear cell Renal Cell Carcinoma identifies novel potential myeloid targets for immunotherapy
DeepTCR: A Deep Learning Framework for Revealing Structural Concepts within TCR Repertoire
Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1
ExCYT: A Graphical User Interface for Streamlining Analysis of High-Dimensional Cytometry Data
DeepTCR: A Deep Learning Framework for Revealing Structural Concepts within TCR Repertoire
DeepTCR: a deep learning framework for revealing structural concepts within TCR Repertoire
Deep Learning of the Immune Synapse
The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer